- Welcome to another installment of our monthly Rare Stock Picks series. Today, we’re highlighting November 2024 investment picks you may have missed.
- As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling ideas hard to come by in today’s market environment.
- The following new investment ideas were made by analysts who have NO OTHER Buy/Strong Buy recommendations in the past 3 months, making them rare selections.
November turned out to be yet another buy the dip opportunity. Even with the SPY up ~27% YTD, are there any compelling investment ideas out there that may have flown under your radar?
Below is a list of November Buy recommendations made by analysts who had no other bullish recommendations over the past 3 months.
For your directory assistance, we’ve classified the opportunities by sector.
Healthcare
Moberg Pharma (OTCPK:MBGPF) – Longtime analyst Michigan Value Investor highlights this under the radar idea with a strong balance sheet and strong earnings power, driven by its toenail fungus treatment, which immediately moved to a 40% market share in Sweden with a broader EU launch set for Q1 2026. – Consider Buying Moberg Pharma Ahead Of Drug Launch
READ FULL ARTICLE HERE!
